Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Regional and systemic chemotherapy for colorectal metastases to the liver
Charles M. Balch
, Bernard Levin
Research output
:
Contribution to journal
›
Article
›
peer-review
6
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Regional and systemic chemotherapy for colorectal metastases to the liver'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Chemotherapy
100%
Liver
100%
Colorectal Metastases
100%
Systemic Chemotherapy
100%
Regional Chemotherapy
100%
Fluoropyrimidine
66%
Drug Infusion
66%
Infusion Pump
66%
Bolus Injection
33%
5-fluorouracil (5-FU)
33%
Patient Selection
33%
Survival Rate
33%
Myelosuppression
33%
Symptomatic Patients
33%
Drug Combination
33%
Improved Survival
33%
Low Quality Data
33%
Intra-arterial Infusion
33%
Dosing Schedule
33%
Liver Toxicity
33%
Antimetabolites
33%
Palliation
33%
Continuous Infusion
33%
High Response Rate
33%
Infusion Therapy
33%
Randomized Prospective Study
33%
Nursing and Health Professions
Drug Infusion
100%
Fluoropyrimidine
100%
Infusion Pump
100%
Palliative Therapy
50%
Infusion
50%
Combination Drug
50%
Survival Rate
50%
Drug Dose Regimen
50%
Intraarterial Drug Administration
50%
Bolus Injection
50%
Infusion Therapy
50%
Continuous Infusion
50%
Liver Toxicity
50%
Antimetabolite
50%
Bone Marrow Suppression
50%
Medicine and Dentistry
Metastatic Carcinoma
100%
Drug Infusion
66%
Fluoropyrimidine
66%
Bolus Injection
33%
Symptomatic Treatment
33%
Prospective Study
33%
Survival Rate
33%
Drug Dose Regimen
33%
Infusion
33%
Bone Marrow Suppression
33%
Combination Drug
33%
Intraarterial Drug Administration
33%
Liver Toxicity
33%
Continuous Infusion
33%
Infusion Therapy
33%
Antimetabolite
33%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Fluoropyrimidine
50%
Infusion Pump
50%
Prospective Study
25%
Survival Rate
25%
Bone Marrow Suppression
25%
Combination Drug
25%
Hepatotoxicity
25%
Antimetabolite
25%
Neuroscience
Fluoropyrimidine
100%